Loading the company…
Loading the company…
㈜가나알엔디
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2014. Industry: Medical & Precision Devices. Revenue for 2025 was ₩19.8bn. It has 32 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2024-08-07 · newest first
본 발명의 실시예에 따르면, 주름 개선을 위한 충진재가 충진된 의료 기기로서, 루어락 타입의 팁; 일단에 상기 팁이 형성되어 있는 외통; 및 상기 외통의 타단으로부터 외통의 길이 방향으로 인입되는 밀대를 포함하고, 상기 외통 내에는, 칼슘 하이드록실아파타이트와 가교된 히알루론산 겔이 충진되어 있는, 의료 기기가 제공된다.
본 발명의 실시예에 따르면, 주름 개선을 위한 충진재가 충진된 의료 기기로서, 루어락 타입의 팁; 일단에 상기 팁이 형성되어 있는 외통; 및 상기 외통의 타단으로부터 외통의 길이 방향으로 인입되는 밀대를 포함하고, 상기 외통 내에는, 폴리엘락틱애씨드와 가교된 히알루론산 겔이 충진되어 있는, 의료 기기가 제공된다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 2 of 2 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 18.2 | 19.8 |
| Cost of sales | 7.6 | 8.2 |
| Gross profit (loss) | 10.6 | 11.6 |
| Selling, general and administrative expenses | 2.3 | 2.7 |
| Operating income (loss) | 8.4 | 8.9 |
| Non-operating income | 0.2 | 0.1 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | 0.1 | 0.1 |
| Non-operating expenses | 0.6 | 0.6 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.6 | 0.6 |
| Other | 0.0 | 0.1 |
| Profit (loss) before tax | 7.9 | 8.3 |
| Income tax expense | 1.7 | 1.7 |
| Net income (loss) | 6.2 | 6.6 |
Revenue ₩19.8bn, up 8.6% YoY.
Operating margin 44.9% (prior 46.0%).
Net income ₩6.6bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06